Is the Beijing Olympic Games worth going to?

According to official website of BIOSETO, the company has many research projects: BIOSETO is developing large-scale drugs for more than 65,438+0,000 potential drug targets ("One thousand mice are drug-resistant" plan), and BIOSETO has signed several cooperative drug development, authorization and transfer agreements, and reached RenMice with dozens of enterprises including multinational companies. Platform cooperation.

The company has broad development prospects: in the future, BIOSETO will continue to work with global partners to continuously produce a variety of antibody drugs to better benefit patients; The company has many institutions: headquartered in Beijing, with branches in China (Haimen, Jiangsu, Shanghai), the United States (Boston, San Francisco) and Heidelberg, Germany.